Huahai pharmaceutical: the net profit in the first quarter is expected to decrease by 41% - 50% year-on-year
Huahai pharmaceutical announced that in the first quarter of 2022, the company is expected to realize a net profit attributable to the parent company of 127-150 million yuan, a year-on-year decrease of about 41% - 50%.
This text is a result of machine translation.
Related companies：
In-depth
Technology
Insta360: Champion the Boldest, Craziest, Wildest of Ideas
The rise of VR camera in today's digital age has already changed the way we record and share our lives. Insta360 (Chinese: 影石), a Chinese tech company founded in 2015, has become a globally renowned intelligent imaging brand thanks to its innovative panoramic technology. Through independent research and continuous technological innovation, the company has met the imaging needs of consumers in different scenarios.
Updated 5 hours ago
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Nov 08, 2022 08:32 AM
Technology
Winall Hi-Tech releases ESG report
Insisting on echnology-first actio.
Yesterday 03:31 PM
Briefing Aug 26, 2021 06:31 PM
· Healthcare
Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Chinese Enterprises are Ready to Tell Stories of Green China at COP28
Dec 02, 2023 12:28 AM
Insight
In-depth